Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case Series.

Autor: Brada MD; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland. murieldiana.brada@usz.ch.; Faculty of Medicine, University of Zurich, Zurich, Switzerland. murieldiana.brada@usz.ch., Rushing EJ; Department of Neuropathology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Bächinger D; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Zoller L; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Burger IA; Department of Nuclear Medicine, Baden Cantonal Hospital, Baden, Switzerland.; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland., Hüllner MW; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Huber A; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Eckhard AH; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.

Publikováno v: Head and neck pathology [Head Neck Pathol] 2022 Dec; Vol. 16 (4), pp. 1012-1018. Date of Electronic Publication: 2022 May 11.

Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI.

Autor: Laudicella R; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 10, 8091, Zurich, Switzerland.; Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy., Rüschoff JH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Ferraro DA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 10, 8091, Zurich, Switzerland.; Department of Radiology and Oncology, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Brada MD; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hausmann D; Department of Radiology, Kantonsspital Baden, Baden, Switzerland.; Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Mebert I; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 10, 8091, Zurich, Switzerland.; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Maurer A; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 10, 8091, Zurich, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Eberli D; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Burger IA; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Rämistrasse 10, 8091, Zurich, Switzerland. Irene.Burger@usz.ch.; Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland. Irene.Burger@usz.ch.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Sep; Vol. 49 (11), pp. 3917-3928. Date of Electronic Publication: 2022 Apr 18.

Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer A Nationwide Multicenter Study.

Autor: Seelen, Leonard W. F., Doppenberg, Deesje, Stoop, Thomas F., Nagelhout, Anne, Brada, Lilly J. H., Bosscha, Koop, Busch, Olivier R., Cirkel, Geert A., den Dulk, Marcel, Daams, Freek, van Dieren, Susan, van Eijck, Casper H. J., Festen, Sebastiaan, Koerkamp, Bas Groot, Mohammad, Nadia Haj, de Hingh, Ignace H. J. T., Lips, Daan J., Los, Maartje, de Meijer, Vincent E., Patijn, Gijs A.

Publikováno v: Annals of Surgery; May2024, Vol. 279 Issue 5, p832-841, 10p

Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence.

Autor: Li Y; Department of Nuclear Medicine, Qilu Hospital of Shandong University, No. 107, Cultural West Road, Jinan, 250012, China., Wang S; Evomics Medical Technology Co., Ltd, Shanghai, China., Zhao S; Department of Radiology, Rizhao Hospital of Traditional Chinese Medicine, No. 35 Wanghai Road, Rizhao, 276800, China., Zhao P; Department of Nuclear Medicine, Jinan Yaoying Medical Imaging Center, Jinan, 250012, China., Huang S; Department of Nuclear Medicine, Qilu Hospital of Shandong University, No. 107, Cultural West Road, Jinan, 250012, China., Li K; Department of Nuclear Medicine, Qilu Hospital of Shandong University, No. 107, Cultural West Road, Jinan, 250012, China., Han S; Evomics Medical Technology Co., Ltd, Shanghai, China., Tian C; Evomics Medical Technology Co., Ltd, Shanghai, China., Li X; Department of Nuclear Medicine, Qilu Hospital of Shandong University, No. 107, Cultural West Road, Jinan, 250012, China. lixin16@sdu.edu.cn., Shi B; Department of Urology, Qilu Hospital of Shandong University, No. 107, Cultural West Road, Jinan, 250012, China. bkang68@sdu.edu.cn., Li X; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. xiang.li@meduniwien.ac.at.; Department of Nuclear Medicine, Beijing Chest Hospital, Beijing, China. xiang.li@meduniwien.ac.at.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (8), pp. 2458-2466. Date of Electronic Publication: 2024 Apr 02.

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study.

Autor: Vermassen T; Department Medical Oncology, University Hospital Ghent, Corneel Heymanslaan 10, Ghent, Belgium. tijl.vermassen@uzgent.be.; Biomarkers in Cancer, Ghent University, Ghent, Belgium. tijl.vermassen@uzgent.be.; Cancer Research Institute Ghent, Ghent, Belgium. tijl.vermassen@uzgent.be., De Keukeleire S; Department Internal Medicine, University Hospital Brussels, Brussels, Belgium., Saerens M; Department Medical Oncology, University Hospital Ghent, Corneel Heymanslaan 10, Ghent, Belgium.; Biomarkers in Cancer, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Heerwegh S; Department Medical Oncology, University Hospital Ghent, Corneel Heymanslaan 10, Ghent, Belgium., Debacker JM; Cancer Research Institute Ghent, Ghent, Belgium.; Laboratory for Molecular Imaging and Therapy, Vrije Universiteit Brussel, Brussels, Belgium.; Department Head and Neck Surgery, University Hospital Ghent, Ghent, Belgium., Huvenne W; Cancer Research Institute Ghent, Ghent, Belgium.; Department Head and Neck Surgery, University Hospital Ghent, Ghent, Belgium.; Upper Airway Research Laboratory, Ghent University, Ghent, Belgium., Deron P; Department Head and Neck Surgery, University Hospital Ghent, Ghent, Belgium., Creytens D; Cancer Research Institute Ghent, Ghent, Belgium.; Department Pathology, University Hospital Ghent, Ghent, Belgium.; Department Diagnostic Sciences, Ghent University, Ghent, Belgium., Ferdinande L; Department Pathology, University Hospital Ghent, Ghent, Belgium.; Department Diagnostic Sciences, Ghent University, Ghent, Belgium., Rottey S; Department Medical Oncology, University Hospital Ghent, Corneel Heymanslaan 10, Ghent, Belgium.; Biomarkers in Cancer, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Bachert C; Upper Airway Research Laboratory, Ghent University, Ghent, Belgium.; Department Otorhinolaryngology, University Hospital Ghent, Ghent, Belgium., Duprez F; Cancer Research Institute Ghent, Ghent, Belgium.; Department Radiation Oncology, University Hospital Ghent, Ghent, Belgium.; Department Human Structure and Repair, Ghent University, Ghent, Belgium., Van Zele T; Upper Airway Research Laboratory, Ghent University, Ghent, Belgium.; Department Otorhinolaryngology, University Hospital Ghent, Ghent, Belgium.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Jun; Vol. 281 (6), pp. 2993-3004. Date of Electronic Publication: 2024 Jan 16.